Related Experiment Video
Updated: May 3, 2026

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 18, 2008
[Residual relaxant block due to pseudocholinesterase deficiency - First manifestation in an elderly patient]
Abstract:
Pseudocholinesterase or butyrylcholinesterase (BChE) inactivates the relaxant drugs mivacurium and suxamethonium. A deficiency in plasma activity of this enzyme may result in prolonged muscular paralysis and subsequently the need for an extended duration of mechanical ventilation. We report the case of a 65-year-old patient who was diagnosed with butyrylcholinesterase deficiency for the first time during elective surgery. Neuromuscular monitoring constitutes a central diagnostic asset in ensuring patient safety.
Insights
Butyrylcholinesterase deficiency can cause prolonged paralysis after anesthesia. This case highlights the importance of neuromuscular monitoring for patient safety during surgery.
Area of Science:
- Anesthesiology
- Biochemistry
Background:
- Pseudocholinesterase (BChE) is crucial for metabolizing neuromuscular blocking agents like mivacurium and suxamethonium.
- Reduced BChE activity can lead to prolonged effects of these anesthetic drugs.
Observation:
- A 65-year-old patient undergoing elective surgery was found to have previously undiagnosed BChE deficiency.
- The deficiency was identified during the surgical procedure.
Findings:
- The patient's BChE deficiency was diagnosed intraoperatively.
- Neuromuscular monitoring is essential for detecting and managing such deficiencies.
Implications:
- Early diagnosis of BChE deficiency is vital for preventing prolonged paralysis and mechanical ventilation.
- This case underscores the critical role of neuromuscular monitoring in anesthetic practice for patient safety.
More Related Videos
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Depolarizing Blockers: Pharmocokinetics
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Skeletal Muscle Relaxants: Therapeutic Uses
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...

